• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Codexis Inc (NQ: CDXS )

    3.185 +0.085 (+2.74%)
    Streaming Delayed Price Updated: 12:43 PM EDT, Oct 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Codexis Inc

    < Previous 1 2 3 Next >
    CDXS Stock Earnings: Codexis Misses EPS, Beats Revenue for Q2 2024
    CDXS stock results show that Codexis missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    CDXS Stock Earnings: Codexis Beats EPS, Beats Revenue for Q1 2024
    CDXS stock results show that Codexis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Recap: Codexis Q4 Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Recap: Codexis Q1 Earnings
    Via Benzinga
    Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough
    Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).  
    Via Benzinga
    “Dyadic International Inc. (NASDAQ: DYAI) Advances Biopharmaceutical Innovations and Vaccine Manufacturing Globally”
    Via AB Newswire
    Exposures COVID-19
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket
    Shares of Nxu, Inc. (NASDAQ: NXU) rose sharply in pre-market trading after the company signed a letter of intent outlining investment in Lynx Motors. Nxu, shares rose 42.1% to $0.0278 in pre-market... 
    Via Benzinga
    Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    3 Synthetic Biology Stocks Likely to Mint New Millionaires
    Synthetic biology stocks are strongly worth considering for several reasons, particularly these three stocks. 
    Via InvestorPlace
    The Next Nvidia: 3 AI Stocks That Could Break New Records
    While trying to find the next Nvidia is a wildly risky proposition, these AI stocks to buy could be your ticket to extraordinary gains. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Cathie Wood Mops Up $8.1M Worth Of Zoom Stock After Q2 Earnings Beat, Sells Nvidia Shares In Excess Of $1M
    Via Benzinga
    Topics Earnings
    Exposures Financial
    Cathie Wood Sells Shopify Shares Worth $9.2M — Ark Goes Shopping This Dutch Payment Company's Stock Instead
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Codexis' Strategic Focus: Discontinues Biotherapeutics Development, Lays Off 25% Of Employees, Cash Runway Into Mid-2026
    Codexis Inc (NASDAQ: CDXS) intends to prioritize advancing and commercializing its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis platform and its  
    Via Benzinga
    Cathie Wood's Ark Invest Makes Major Quantum-Si Purchase — Loads Up On 1.4M Shares Of Semiconductor Firm
    Via Benzinga
    Cathie Wood's Ark Invest Continues Tesla Selling Spree Despite Stock's Rise, AI Potential
    Via Benzinga
    Time to Evolve: 3 Synthetic Biology Stocks to Sell Off Now
    The biotech boom has become a biotech bust. Many companies still have further to fall, so sell these three before they hit rock bottom. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
    Via Benzinga
    Codexis Shelves Development Of Certain Internal Programs, Cuts Workforce
    Via Benzinga
    Earnings Outlook For Codexis
    Codexis (NASDAQ:CDXS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Codexis will report... 
    Via Benzinga
    Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
    Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.